We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Advanced Instruments Acquires Manufacturer of Anaerobic Instruments

By Labmedica staff writers
Posted on 27 Nov 2007
Advanced Instruments, Inc. More...
(Norwood, MA, USA) has acquired Mart Microbiology B.V. (Lichtenwoorde, The Netherlands). The terms of the transaction were not disclosed.

Mart Microbiology manufactures and markets the Anoxomat line of instruments. These systems create custom environments for anaerobic bacteria cultivation, a process that requires oxygen-deprived atmospheres. They are used for the diagnosis of post-operative infection in hospitals and clinics, plus bacterial cultivation in food microbiology laboratories.

Anoxomat provides many advantages over traditional methods of cultivating anaerobes. The system can quickly create a precision anaerobic environment that enables reliable and rapid bacteria cultivation. It uses less lab space than traditional "glove box” cabinets and can provide typical returns on investment in less than one year.

The system rapidly and automatically creates anaerobic, micro-aerophilic, or capnophilic conditions in an anaerobic jar. It uses precise pressure measurements guided by an embedded computer to control the evacuation and refilling of the anaerobic jar. The touch screen display allows the user to simply enter the desired percentages of oxygen and other gases, and to save these ‘recipes' for future reference.

Advanced Instruments has been the U.S. distributor of Anoxomat products for more than six years and has placed many systems at leading American medical centers. In addition, Mart products are sold in other global regions through an established factory-trained dealer network.

"Mart Microbiology is a perfect fit for our company,” said John Coughlin, president and CEO, Advanced Instruments. "It is the clear market leader in this developing technology and compliments our company's market presence globally. The experience gained as Anoxomat's U.S. distributor gives us a high degree of confidence in making this strategic move,” he said.

Advanced Instruments currently operates a facility in The Netherlands and it is anticipated that the operations of Mart Microbiology will be integrated into that facility sometime in the near future.


Related Links:
Advanced Instruments
Mart Microbiology B.V.

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.